Needham analyst Alex Henderson initiates coverage on HashiCorp (NASDAQ:HCP) with a Hold rating.
BD Launches First-in-Human Trial Of Sirolimus Drug-Coated Balloon To Expand Treatment Options For Peripheral Arterial Disease
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, has announced the start of enrollment in a first-in-human trial of a peripheral sirolimus drug-coated balloon (DCB).
BD is a
